HIGHLIGHTS
- who: Xiaocong Wu from the (UNIVERSITY) have published the research work: A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2, in the Journal: (JOURNAL)
- what: The study showed that may be an and promising prognostic biomarker in certain types of tumors. The authors investigated the biological functions of SHOX2 in a variety of cancers. The authors first revealed that the SHOX2 mRNA expression were higher in various tumors compared with normal tissues, including ACC, BLCA, COAD, CHOL, ESCA, GBM, HNSC, KIRP, KIRC, LGG, LIHC, LUSC, LUAD, OV, PRAD, PAAD, READ, STAD, UCEC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.